Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
Talphera Inc (TLPH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid Financial Challenges
Despite a revenue-free quarter, Talphera Inc (TLPH) progresses in clinical trials and secures significant funding, setting a robust groundwork for future growth. May 15, 2024
GuruFocus Research Drug Manufacturers
CV Sciences Inc (CVSI) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with Strategic Acquisitions and Market Leadership
Despite a mixed financial performance, CV Sciences Inc (CVSI) focuses on growth through strategic acquisitions and maintaining market dominance in the natural product sector. May 15, 2024
GuruFocus Research Drug Manufacturers
Rockwell Medical Inc (RMTI) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Optimistic Projections
Amidst financial challenges, Rockwell Medical Inc (RMTI) showcases a robust sales increase and strategic market expansions in Q1 2024. May 15, 2024
GuruFocus Research Drug Manufacturers
Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges and Clinical Advances
Amidst revenue decline and significant cash burn, Durect Corp reports promising clinical trial results and strategic FDA interactions. May 14, 2024